A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma

Martin H. Voss, A. Hussain, N. Vogelzang, J. L. Lee, B. Keam, S. Y. Rha, U. Vaishampayan, W. B. Harris, S. Richey, J. M. Randall, D. Shaffer, A. Cohn, T. Crowell, J. Li, A. Senderowicz, E. Stone, R. Figlin, R. J. Motzer, N. B. Haas, T. Hutson

Research output: Contribution to journalArticlepeer-review

26 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences